Sign inJoin waitlistJoin the waitlist

Jade Jones

Physician · Emory University School of Medicine

Credentials: · · · · ·

History

Emory University School of Medicine
2020–Present

Hematology and Medical Oncology
University of Texas M D Anderson Cancer Center
2017–2020
Internal Medicine
Vanderbilt University Medical Center
2014–2015
University of North Carolina School of Medicine
2010–2014

Research

Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial
The Lancet Oncology · 2015 · 318 citations
Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib--Findings from an Investigator-Initiated Phase II Study
Clinical Cancer Research · 2016 · 193 citations
Treatment with Ibrutinib Inhibits BTK- and VLA-4-Dependent Adhesion of Chronic Lymphocytic Leukemia Cells In Vivo
Clinical Cancer Research · 2015 · 104 citations

AW
Adrian Wiestner
5 papers
Irina Maric
3 papers
CS
Clare Sun
2 papers · 1 as a fellow
Constance Yuan
2 papers
Deanna Wong
2 papers
GM
Gerald Marti
2 papers
JP
Jamie Paysour
2 papers
Katherine Calvo
2 papers
MS
Maryalice Stetler-Stevenson
2 papers
SM
Sabrina Martyr
2 papers · 1 as a fellow
Stefania Pittaluga
2 papers
Alankrita Taneja
1 paper · 1 as a fellow

Clinical trials

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Site PI · Recruiting · Phase 3
Stemline Therapeutics, Inc.
2024–2032
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2023–2033
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Site PI · Recruiting
SWOG Cancer Research Network
2018–2036